Dicerna Pharmaceuticals
May 23, 2014

Dicerna to Present at Upcoming Conferences

WATERTOWN, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that Douglas M. Fambrough, PhD, President and CEO, will present at Jefferies 2014 Global Healthcare Conference on June 2, 2014, at 10:00am ET in New York, NY. In addition, Dr. Fambrough will participate in the 2014 Biopharma: Trends to Watch panel at the Boston CEO Conference on June 4, 2014, at 10:00am ET in Boston, MA.

A live webcast of the Jefferies presentation can be accessed by visiting "Events & Presentations" in the Investors and Media section on the Company's website at www.dicerna.com. An archived replay of the webcast will be available on the Company's website after the conference.

About Dicerna Pharmaceuticals, Inc.

Dicerna is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers that are genetically defined. Dicerna is using its proprietary RNA interference (RNAi) technology platform to build a broad pipeline in these therapeutic areas and intends to discover, develop and commercialize novel therapeutics either on its own or in collaboration with pharmaceutical partners.

Company:
Dicerna Pharmaceuticals, Inc.
James B. Weissman, 617-621-8097
Chief Business Officer
or
Media:
MacDougall Biomedical Communications
Chris Erdman, 781-235-3060
Senior Vice President
chris@macbiocom.com

Source: Dicerna Pharmaceuticals, Inc.

News Provided by Acquire Media